Posted in health
* https: //www.eventscribe.com/2019/NeuPSIG/aboutcongress.asp A forum that presents the latest research and advances in understanding, preventing and treating neuropathic pain.
A clinical study titled “Interest in Local Treatment for Painful Diabetic Neuropathy,” poster EP-124, demonstrates the value of local treatment for painful diabetic neuropathy.
Diabetic neuropathy includes a group of diabetes complications that can cause pain, numbness, numbness, or loss of sensation (pain, cold, etc.). Between 20% and 60% of people with diabetes (type 1 and type 2) have some form of neuropathy, which can be associated with legs, feet, hands, or arms. 650,000 people suffer from painful neuropathy in France **.
Managing diabetic neuropathy remains a problem. Topical treatment is of great interest due to the frequent side effects caused by oral treatment.
** Management of a diabetic foot in a specialized center K. Van Aker – B. Wandelin – F. Vermassin – T. Lemrieis: ed. Albe de Cocker 2008
The study, conducted by Professor Phillips of the University Hospital of Liege, on 22 patients (12 women / 10 men); Type 1 diabetes: 21.05%; Type 2 diabetes: 78.95%; Duration of LAP and FOOT: 2 times a day for 1 month.
The results of the EVAUX® study show, after one month of use of PIEDS & LEGS, a significant reduction in pain and, in particular, pain symptoms, as indicated in the DN4 questionnaire.
• painful cold
• electric shock
Symptoms of the DN4 questionnaire are reduced from 30% to 67%.
58% of patients report a reduction in pain at the end of the study (1 month).
47% of patients would like to continue using the product PIEDS & LEVES.
The use of FEET & LEGS causes a decrease in pain in more than half of the patients, who praised the convenience and ease of use.
ABOUT PRODUCT LEGS AND LEGS
Product PIEDS & LEGS, gel cream, designed to care for lower limbs, is designed to maintain high-quality skin and soothe neuropathic genes.
PIEDS & LEVES is sold in pharmacies
Non-greasy cream gel
Pump bottle for presentations 250ml
ACL code 3760031691185 – CNK code 3782-661
Recommended retail price 19.80 €
The PIEDS & LEGS product is also the subject of a clinical study at the Fagnes Health Center (Chimay – Belgium), a branch of Dr. Christian Van Acker. "Evaluation of the effectiveness of cream-gel PIEDS & LEGS compared with Dexeryl® in primary prevention in patients with type 1 or type 2 diabetes: restoration of hydration." The preliminary results are very convincing.
EVAUX®, a French dermatological laboratory, is developing its experience in the field of dermo-cosmetic care based on the properties of hyperthermic water from Evaux les Bains, France. Numerous medical studies have confirmed the effectiveness of EVAUX® dermo-cosmetic products. EVAUX® products are freely available in pharmacies and other specialty stores. International markets are currently the goal of the laboratory.
statement sent to 2019-05-10 12:08:15 through Categorynet.com website in the Health section
Broadcast your press release: http://www.diffuseruncommuniquedepresse.com